Article Versions Notes

Boldrin E, Piano MA, Volpato A, Alfieri R, Franco M, Morbin T, Masier A, Realdon S, Mattara G, Magni G, et al. Global Hypomethylation as Minimal Residual Disease (MRD) Biomarker in Esophageal and Esophagogastric Junction Adenocarcinoma. Cancers. 2025; 17(16):2668. https://doi.org/10.3390/cancers17162668

Boldrin, Elisa, Maria Assunta Piano, Alice Volpato, Rita Alfieri, Monica Franco, Tiziana Morbin, Annalisa Masier, Stefano Realdon, Genny Mattara, Giovanna Magni, and et al. 2025. "Global Hypomethylation as Minimal Residual Disease (MRD) Biomarker in Esophageal and Esophagogastric Junction Adenocarcinoma" Cancers 17, no. 16: 2668. https://doi.org/10.3390/cancers17162668

Boldrin, E., Piano, M. A., Volpato, A., Alfieri, R., Franco, M., Morbin, T., Masier, A., Realdon, S., Mattara, G., Magni, G., Rosato, A., Pilati, P., Fantin, A., & Curtarello, M. (2025). Global Hypomethylation as Minimal Residual Disease (MRD) Biomarker in Esophageal and Esophagogastric Junction Adenocarcinoma. Cancers, 17(16), 2668. https://doi.org/10.3390/cancers17162668